Cargando…
Interleukin-2 receptor and ovarian cancer.
Interleukin-2 receptor (IL-2R) can be detected in serum. We estimated the IL-2R in the serum of 78 women, of whom 30 were diagnosed as having malignant ovarian tumours, five had non ovarian tumours, one had a negative second look laparotomy, 11 had benign ovarian tumours, three had uterine fibroids...
Autores principales: | Owens, O. J., Taggart, C., Wilson, R., Walker, J. J., McKillop, J. H., Kennedy, J. H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968563/ https://www.ncbi.nlm.nih.gov/pubmed/8347492 |
Ejemplares similares
-
Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model
por: Berger, Alexandra, et al.
Publicado: (2019) -
Neurology and Psychiatry
por: Ell, P J, et al.
Publicado: (1998) -
Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases.
por: Goldberg, J. A., et al.
Publicado: (1988) -
Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts
por: El-Zawahry, Ahmed, et al.
Publicado: (2005) -
Epidermal growth factor receptors (EGFR) in human ovarian cancer.
por: Owens, O. J., et al.
Publicado: (1991)